AmbioPharm, Inc. is a leading peptide manufacturer with FDA-inspected facilities in Carlsbad, CA, and Shanghai, China. With one of the largest peptide manufacturing capacities worldwide, AmbioPharm offers a unique API model that allows for expedited peptide manufacturing at a lower cost than most major competitors. Their team of over 500 chemists and industry professionals is dedicated to providing best-in-class quality and efficient production, handling projects of any scale from gram to multi-kilogram. AmbioPharm's services range from GMP and non-GMP peptide synthesis to vaccine manufacturing, analytical development, and quality compliance, serving pharmaceutical companies, clinical research labs, universities, and biotech companies.
Generated from the website